PUBLIC CONTRACT · 2022
Medicamento BEVAcizumab 400 mg/16 ml Sol inj Fr 16 ml IV (I) SPMS
- Contract value
- €44,703.00
- Signed on
- 24 November 2022
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9977639PUBLISHED SUBJECT
61/184/2023 - Medicamento BEVAcizumab 400 mg/16 ml Sol inj Fr 16 ml IV (I) SPMS
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ZENTIVA · Tax ID 503103551
Values and timeline
- Contract price
- €44,703.00
- Procedure base price
- €44,703.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 May 2023
- Award date
- 24 November 2022
- Signing date
- 24 November 2022
- Performance period
- 92 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6488821
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.